Any current/future capex/capital investment/strategic investment?

FY ’23 capex was around INR 28 crores, adding approximately 1,600 tons of capacity (mainly pails machine and a small machine for SBM). Current capacity utilization is ~67%, approaching peak levels (70-75%). Plans for further capacity expansion are under consideration; the company will announce details soon after board approval. Expansion mode is ongoing with new capacity additions planned but timing and specifics to be disclosed later. New pails product line capacity is 1,600 tons with a target of 60% utilization in FY ’24. Continuous in-house R&D and new product development efforts are ongoin

Future growth expectations in sales/revenue/volumes?

The company is on a growth path and expects better growth going forward, not benchmarking FY ‘22-‘23 as it was a special low year. With current capacity, the company can achieve approximately INR 425 crores top line without new capacity additions. Capacity expansions are under consideration and will be announced soon after board approval. The focus is on increasing capacity utilization with current capacity at around 67%. For FY ‘24, volume growth of around 10%-15% is expected, while maintaining or improving realizations per kg. The pails segment (capacity 1,600 tons) targets 60% uti

Future growth expectations in earnings/operating earnings/profits/EPS?

Mitsu Chem Plast Limited is targeting an EBITDA margin of around 13%, aiming to sustain more than double-digit margins going forward. For FY24, the company expects around INR 425 crores top line from current capacity without any new machine installations, indicating growth potential with capacity expansion. Capacity expansion plans are underway, expected to be announced soon after board approval, which should further drive growth. Volume growth expectation for FY24 is positive, with analysts suggesting 10-15% volume growth; realization per kg might maintain FY23 levels. New product seg

Current/ Expected Orderbook/ Pending Orders?

The order book inflow from clients is reported as good, including for the current quarter. Hospital furniture demand is strong, supported by significant infrastructure development in India. The hospital furniture segment, although capital intensive with cyclical demand, is experiencing substantial order flow. No explicit numerical value for total order book or pending orders is provided. New product developments are underway, and announcements will be made once ready, indicating potential future order inflows. There is optimism about the market conditions improving in FY '24, suggesting positi

IN US

Sale is live|00:00:00left today

Mitsu Chem Plast LtdQ1 FY23Industrial Products

Mitsu Chem Plast Ltd Q1 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹151P/E: 9.6Market Cap: ₹151 CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→The company is on a growth path and expects better growth going forward, not benchmarking FY ‘22-‘23 as it was a special low year.
→With current capacity, the company can achieve approximately INR 425 crores top line without new capacity additions.
→Capacity expansions are under consideration and will be announced soon after board approval.
→The focus is on increasing capacity utilization with current capacity at around 67%.
→For FY ‘24, volume growth of around 10%-15% is expected, while maintaining or improving realizations per kg.
→The pails segment (capacity 1,600 tons) targets 60% utilization in FY ‘24 with EBITDA margins between 14%-18%.
→Overall, the market demand looks positive for FY ‘24 with ongoing customer additions and new product launches potentially driving revenue growth.

Margin guidance

Category 3

→Mitsu Chem Plast Limited is targeting an EBITDA margin of around 13%, aiming to sustain more than double-digit margins going forward.
→For FY24, the company expects around INR 425 crores top line from current capacity without any new machine installations, indicating growth potential with capacity expansion.
→Capacity expansion plans are underway, expected to be announced soon after board approval, which should further drive growth.
→Volume growth expectation for FY24 is positive, with analysts suggesting 10-15% volume growth; realization per kg might maintain FY23 levels.
→New product segments like pails (with 1,600-ton capacity and 60% utilization targeted) offer EBITDA margins between 14-18%, adding to profitability.
→The company expects market demand and cost optimization to favorably influence margins and profits.
→FY23 results showed EBITDA of INR 26.60 crores and PAT of INR 11.80 crores, with management confident of building on these results.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

- Current debt status: Many term loans have been paid off; only cash credit (CC) working capital debt remains (~INR 80 crores). - Debt reduction plans: Fixed Pay Offer (FPO) is a plan under consideration, but not confirmed; alternative plans will be explored if FPO does not happen. - No explicit mention of new debt fundraising. - Equity fundraising via FPO is the main potential plan, but it is not finalized yet. - Capacity expansion plans are under board consideration and will be announced when finalized, implying potential future fundraising but no specifics provided. In summary, no confirmed new fundraising is underway; FPO (equity) is the primary planned route for debt reduction and possible expansion, with alternative plans to be strategized if FPO does not materialize.

Order book

Yes

→The order book inflow from clients is reported as good, including for the current quarter.
→Hospital furniture demand is strong, supported by significant infrastructure development in India.
→The hospital furniture segment, although capital intensive with cyclical demand, is experiencing substantial order flow.
→No explicit numerical value for total order book or pending orders is provided.
→New product developments are underway, and announcements will be made once ready, indicating potential future order inflows.
→There is optimism about the market conditions improving in FY '24, suggesting positive order trends ahead.

Capex plans

Yes

→FY ’23 capex was around INR 28 crores, adding approximately 1,600 tons of capacity (mainly pails machine and a small machine for SBM).
→Current capacity utilization is ~67%, approaching peak levels (70-75%).
→Plans for further capacity expansion are under consideration; the company will announce details soon after board approval.
→Expansion mode is ongoing with new capacity additions planned but timing and specifics to be disclosed later.
→New pails product line capacity is 1,600 tons with a target of 60% utilization in FY ’24.
→Continuous in-house R&D and new product development efforts are ongoing, with new products to be launched post successful testing.
→No explicit mention of strategic investments beyond capacity and product expansion in packaging and pails segments currently.

How does Mitsu Chem Plast Ltd rank vs peers in Industrial Products?

Pro feature

1Mitsu Chem Plast Ltd

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like Mitsu Chem Plast Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio